Found: 15
Select item for more details and to access through your institution.
Personalized treatment of hepatitis B.
- Published in:
- Clinical & Molecular Hepatology, 2015, v. 21, n. 1, p. 1, doi. 10.3350/cmh.2015.21.1.1
- By:
- Publication type:
- Article
Clinical implications of advances in liver regeneration.
- Published in:
- Clinical & Molecular Hepatology, 2015, v. 21, n. 1, p. 7, doi. 10.3350/cmh.2015.21.1.7
- By:
- Publication type:
- Article
The cost of liver disease in Korea: methodology, data, and evidence.
- Published in:
- Clinical & Molecular Hepatology, 2015, v. 21, n. 1, p. 14, doi. 10.3350/cmh.2015.21.1.14
- By:
- Publication type:
- Article
Regression of liver cirrhosis: Orthodoxy or paradigm shift?
- Published in:
- Clinical & Molecular Hepatology, 2015, v. 21, n. 1, p. 22, doi. 10.3350/cmh.2015.21.1.22
- By:
- Publication type:
- Article
Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir.
- Published in:
- Clinical & Molecular Hepatology, 2015, v. 21, n. 1, p. 24, doi. 10.3350/cmh.2015.21.1.24
- By:
- Publication type:
- Article
The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B.
- Published in:
- Clinical & Molecular Hepatology, 2015, v. 21, n. 1, p. 32, doi. 10.3350/cmh.2015.21.1.32
- By:
- Publication type:
- Article
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients.
- Published in:
- Clinical & Molecular Hepatology, 2015, v. 21, n. 1, p. 41, doi. 10.3350/cmh.2015.21.1.41
- By:
- Publication type:
- Article
Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells.
- Published in:
- Clinical & Molecular Hepatology, 2015, v. 21, n. 1, p. 49, doi. 10.3350/cmh.2015.21.1.49
- By:
- Publication type:
- Article
Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2015, v. 21, n. 1, p. 60, doi. 10.3350/cmh.2015.21.1.60
- By:
- Publication type:
- Article
Alteration of laboratory findings after radiofrequency ablation of hepatocellular carcinoma: relationship to severity of the underlying liver disease and the ablation volume.
- Published in:
- Clinical & Molecular Hepatology, 2015, v. 21, n. 1, p. 71, doi. 10.3350/cmh.2015.21.1.71
- By:
- Publication type:
- Article
A case of primary hepatic actinomycosis: an enigmatic inflammatory lesion of the liver.
- Published in:
- Clinical & Molecular Hepatology, 2015, v. 21, n. 1, p. 80, doi. 10.3350/cmh.2015.21.1.80
- By:
- Publication type:
- Article
Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient.
- Published in:
- Clinical & Molecular Hepatology, 2015, v. 21, n. 1, p. 85, doi. 10.3350/cmh.2015.21.1.85
- By:
- Publication type:
- Article
Budd-Chiari syndrome with multiple large regenerative nodules.
- Published in:
- Clinical & Molecular Hepatology, 2015, v. 21, n. 1, p. 89, doi. 10.3350/cmh.2015.21.1.89
- By:
- Publication type:
- Article
Recent advances in the imaging of hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2015, v. 21, n. 1, p. 95, doi. 10.3350/cmh.2015.21.1.95
- By:
- Publication type:
- Article
Erratum.
- Published in:
- Clinical & Molecular Hepatology, 2015, v. 21, n. 1, p. 104, doi. 10.3350/cmh.2015.21.1.104
- Publication type:
- Article